Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seattle Genetics IncfiledCriticalSeattle Genetics Inc
Publication of TR201905240T4publicationCriticalpatent/TR201905240T4/en
Mevcut buluş, LIV-1'e spesifik olarak bağlanan hümanize antikorlar sağlamaktadır. Antikorlar, LIV-1'i tespit etmenin yanı sıra, çeşitli kanserlerin tedavisi ve teşhisi için faydalıdır.The present invention provides humanized antibodies that specifically bind to LIV-1. In addition to detecting LIV-1, antibodies are useful for the treatment and diagnosis of various cancers.
TR2019/05240T2011-02-252011-12-06
Humanized antibodies to LIV-1 and their use in the treatment of cancer.
TR201905240T4
(en)